Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 14, 2012

Commentary: Environmental, genetic factors play roles in getting MS

  • Multiple Sclerosis
    /
By James Winkley — Special to the Herald-Leader Posted: Feb 13, 2012 When I tell a patient he or she has…
Multiple Sclerosis

February 14, 2012

An MS Patient’s Story – Swept off my feet by the smart, sweet, gentle, handy man

  • An MS Patients Story
    /
  • Caregiver related
    /
Column by Joan Herman / For The Daily News | Posted: Monday, February 13, 2012 For years after my marriage ended, I dated…
An MS Patients Story

February 14, 2012

The MS Dream Center of Rhode Island

  • Caregiver related
    /
  • Multiple Sclerosis
    /
The MS Dream Center – R.I. is to engage all members with MS in purposeful activity, while promoting a spirit…
Caregiver related

February 14, 2012

Immunological Markers of Optimal Response to Natalizumab (Tysabri) in Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Tysabri
    /
Luisa M. Villar, PhD; María I. García-Sánchez, PhD; Lucienne Costa-Frossard, MD; Mercedes Espiño, PhD; Ernesto Roldán, PhD; Dolores Páramo, MD; Miguel Lucas, PhD;Guillermo Izquierdo, …
MS Research Study and Reports

February 14, 2012

The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical trial on TDI 132 (aka: fingolimod/Gilenya(R)) as a potential treatment for ALS (Lou Gehrig’s disease)

  • Misc. MS Related
    /
Feb 14, 2012 CAMBRIDGE, Mass., Feb. 14, 2012 /PRNewswire-USNewswire/ — The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical…
Misc. MS Related

February 14, 2012

A flowering Tibetan shrub that tricks cells into thinking they are starving could become a weapon against multiple sclerosis and even old age

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
February 13, 2012 The roots of the blue evergreen hydrangea (Dichroa febrifuga) have been used for centuries in traditional Chinese medicine to…
Alternative therapies and devices for Multiple Sclerosis (MS)

February 13, 2012

Masitinib in Patients With Primary Progressive or Relapse-free Secondary Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
A 96 Week, Prospective, Multicentre, Randomized, Double-blind, Placebo-controlled, 2 Parallel-groups, Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib…
MS Drug Therapies

February 11, 2012

Caltech researchers report potential MS breakthrough

  • MS Research Study and Reports
    /
February 9, 2012 Caltech researchers report a possible breakthrough in multiple sclerosis medicine in the latest issue of the Journal of Neuroscience.…
MS Research Study and Reports

February 11, 2012

New book offers advice on speaking to MS patients

  • An MS Patients Story
    /
Author: Ursula Pari, Anchor San Antonio – Dr. Dee Kite has written numerous books from fiction to self-help, but her latest one…
An MS Patients Story

February 11, 2012

Treating Early MS By Targeting Inflammation?

  • Multiple Sclerosis
    /
Laurie L. Barclay, MD Authors and Disclosures Posted: 02/09/2012 Inflammatory Cortical Demyelination in Early Multiple Sclerosis Lucchinetti CF, Popescu BF,…
Multiple Sclerosis

Categories

Latest Blog Posts